eSignal IPO Calendar

Week of Expected Pricing	Pending
Company Name	Rib X Pharmaceuticals, Inc.
Proposed Ticker	RIBX
CUSIP	N/A
Business Description	A biopharmaceutical company developing new antibiotics to provide superior coverage, safety and convenience for the treatment of serious and life-threatening infections.
Lead Underwriter	Deutsche Bank Securities, Inc.
Co-Managers	Lazard Capital Markets LLC, Needham & Company, LLC, William Blair and Co., L.L.C
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A